Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel‐glass ionic dissolution products
Source abstract
Abstract
Abstract Bioactive glasses dissolve upon immersion in culture medium, releasing their constitutive ions in solution. There is evidence suggesting that these ionic dissolution products influence osteoblast‐specific processes. Here, we investigated the effect of 58S sol–gel‐derived bioactive glass (60 mol % SiO2, 36 mol % CaO, 4 mol % P2O5) dissolution products on primary osteoblasts derived from human fetal long bone explant cultures (hFOBs). We used U133A human genome GeneChip® oligonucleotide arrays to examine 22,283 transcripts and variants, which represent over 18,000 well‐substantiated human genes. Hybridization of samples (biotinylated cRNA) derived from monolayer cultures of hFOBs on the arrays revealed that 10,571 transcripts were expressed by these cells, with high confidence. These included transcripts representing osteoblast‐related genes coding for growth factors and their associated molecules or receptors, protein components of the extracellular matrix (ECM), enzymes involved in degradation of the ECM, transcription factors, and other important osteoblast‐associated markers. A 24‐h treatment with a single dosage of ionic products of sol–gel 58S dissolution induced the differential expression of a number of genes, including IL‐6 signal transducer/gp130, ISGF‐3/STAT1, HIF‐1 responsive RTP801, ERK1 p44 MAPK (MAPK3), MAPKAPK2, IGF‐I and IGFBP‐5. The over 2‐fold up‐regulation of gp130 and MAPK3 and down‐regulation of IGF‐I were confirmed by real‐time RT‐PCR analysis. These data suggest that 58S ionic dissolution products possibly mediate the bioactive effect of 58S through components of the IGF system and MAPK signaling pathways. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. 10.1023/A:100864330388810.1023/A:1008643303888 ↗
2. 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-610.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6 ↗
3. 10.1126/science.106740410.1126/science.1067404 ↗
4. 10.1002/jbm.125010.1002/jbm.1250 ↗
5. 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D ↗
6. 10.1006/bbrc.2000.350310.1006/bbrc.2000.3503 ↗
7. 10.1089/10763270032085610.1089/107632700320856 ↗
8. 10.1016/j.biomaterials.2003.09.08610.1016/j.biomaterials.2003.09.086 ↗
9. 10.1038/444710.1038/4447 ↗
10. Gene array analysis of osteoblast differentiation
11. 10.1006/bbrc.2001.619610.1006/bbrc.2001.6196 ↗
12. 10.1006/bbrc.2001.445810.1006/bbrc.2001.4458 ↗
13. 10.1016/S8756-3282(01)00699-810.1016/S8756-3282(01)00699-8 ↗
14. 10.1002/jcb.1051410.1002/jcb.10514 ↗
15. 10.1016/S8756-3282(03)00052-810.1016/S8756-3282(03)00052-8 ↗
16. 10.1016/S0039-128X(01)00168-410.1016/S0039-128X(01)00168-4 ↗
17. 10.1007/s00774-003-0419-510.1007/s00774-003-0419-5 ↗
18. 10.1359/jbmr.2001.16.12.219210.1359/jbmr.2001.16.12.2192 ↗
19. 10.1359/jbmr.2002.17.12.210610.1359/jbmr.2002.17.12.2106 ↗
20. 10.1359/jbmr.2002.17.12.211910.1359/jbmr.2002.17.12.2119 ↗
21. 10.1002/jcb.1051510.1002/jcb.10515 ↗
22. 10.1016/S8756-3282(03)00116-910.1016/S8756-3282(03)00116-9 ↗
23. 10.1359/jbmr.2003.18.7.117710.1359/jbmr.2003.18.7.1177 ↗
24. 10.1359/JBMR.04021610.1359/JBMR.040216 ↗
25. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
26. 10.1002/jbm.1020710.1002/jbm.10207 ↗
27. 10.1359/jbmr.2001.16.2.23110.1359/jbmr.2001.16.2.231 ↗
28. 10.1007/s00223000113410.1007/s002230001134 ↗
29. 10.1002/jbm.b.3024910.1002/jbm.b.30249 ↗
30. 10.1016/j.bone.2004.07.00110.1016/j.bone.2004.07.001 ↗
31. 10.1002/jbm.1002610.1002/jbm.10026 ↗
32. 10.4028/www.scientific.net/KEM.192-195.62910.4028/www.scientific.net/KEM.192-195.629 ↗
33. 10.1002/jbm.a.1053210.1002/jbm.a.10532 ↗
34. Horowitz MC · 2002 · 961
35. 10.1006/cyto.2000.074710.1006/cyto.2000.0747 ↗
36. 10.1182/blood.V86.4.1243.bloodjournal864124310.1182/blood.V86.4.1243.bloodjournal8641243 ↗
37. 10.1172/JCI11843210.1172/JCI118432 ↗
38. 10.1016/S0021-9258(17)37590-710.1016/S0021-9258(17)37590-7 ↗
39. 10.1210/endo.137.4.862588310.1210/endo.137.4.8625883 ↗
40. 10.4049/jimmunol.169.6.335310.4049/jimmunol.169.6.3353 ↗
41. 10.1152/ajpendo.1999.276.3.E46510.1152/ajpendo.1999.276.3.E465 ↗
42. 10.1042/bj334029710.1042/bj3340297 ↗
43. 10.1093/emboj/19.11.239910.1093/emboj/19.11.2399 ↗
44. 10.1006/excr.2002.562710.1006/excr.2002.5627 ↗
45. 10.1210/en.2003-083910.1210/en.2003-0839 ↗
46. 10.1172/JCI1987210.1172/JCI19872 ↗
47. 10.1210/en.138.11.495910.1210/en.138.11.4959 ↗
48. 10.1210/endo.138.9.536410.1210/endo.138.9.5364 ↗
49. Activation of the JAK‐STAT signal transduction pathway by oncostatin‐M in cultured human and mouse osteoblastic cells10.1210/endo.137.4.8625884 ↗
50. 10.1016/S1074-7613(00)80501-410.1016/S1074-7613(00)80501-4 ↗
51. 10.1073/pnas.89.16.784010.1073/pnas.89.16.7840 ↗
52. 10.1359/jbmr.1998.13.5.77710.1359/jbmr.1998.13.5.777 ↗
53. 10.1038/3506500010.1038/35065000 ↗
54. 10.1359/jbmr.2002.17.1.10110.1359/jbmr.2002.17.1.101 ↗
55. 10.1006/bbrc.1998.915110.1006/bbrc.1998.9151 ↗
56. 10.1002/jcb.121110.1002/jcb.1211 ↗
57. 10.1074/jbc.M01002120010.1074/jbc.M010021200 ↗
58. 10.1006/bbrc.2000.395510.1006/bbrc.2000.3955 ↗
59. 10.1074/jbc.M01092120010.1074/jbc.M010921200 ↗
60. 10.1359/jbmr.2003.18.10.181310.1359/jbmr.2003.18.10.1813 ↗
61. 10.1016/S0006-291X(03)00661-210.1016/S0006-291X(03)00661-2 ↗
62. 10.1016/B978-012098652-1/50147-510.1016/B978-012098652-1/50147-5 ↗
63. 10.1074/jbc.M20826520010.1074/jbc.M208265200 ↗
64. 10.1210/endo.138.9.537010.1210/endo.138.9.5370 ↗
65. 10.1074/jbc.272.1.15410.1074/jbc.272.1.154 ↗
66. 10.1006/bbrc.1998.872810.1006/bbrc.1998.8728 ↗
67. 10.1016/S8756-3282(00)00400-210.1016/S8756-3282(00)00400-2 ↗
68. 10.1074/jbc.270.18.1077110.1074/jbc.270.18.10771 ↗
69. 10.1210/en.136.5.200010.1210/en.136.5.2000 ↗
70. 10.1152/ajpendo.1998.275.2.E22210.1152/ajpendo.1998.275.2.E222 ↗
71. 10.1210/endo.140.10.708110.1210/endo.140.10.7081 ↗
72. 10.1172/JCI1045910.1172/JCI10459 ↗
73. 10.1677/joe.0.175001910.1677/joe.0.1750019 ↗
74. 10.1074/jbc.M11087220010.1074/jbc.M110872200 ↗
75. 10.1210/endo.140.10.706110.1210/endo.140.10.7061 ↗
76. 10.1074/jbc.274.15.1060910.1074/jbc.274.15.10609 ↗
77. 10.1210/en.2003-035010.1210/en.2003-0350 ↗
78. 10.1006/bbrc.1998.840310.1006/bbrc.1998.8403 ↗
79. 10.1152/ajpendo.1994.266.5.E70910.1152/ajpendo.1994.266.5.E709 ↗
80. 10.1002/jcp.1006710.1002/jcp.10067 ↗
81. 10.1210/endo.138.12.556110.1210/endo.138.12.5561 ↗
82. 10.1016/S0092-8674(00)81812-710.1016/S0092-8674(00)81812-7 ↗
83. 10.1016/S0092-8674(00)81813-910.1016/S0092-8674(00)81813-9 ↗
84. 10.1016/S8756-3282(00)00422-110.1016/S8756-3282(00)00422-1 ↗
85. 10.1016/0165-6147(88)90015-610.1016/0165-6147(88)90015-6 ↗
86. 10.1111/j.1600-065X.1998.tb01577.x10.1111/j.1600-065X.1998.tb01577.x ↗
87. Human carboxypeptidase M: Purification and characterisation of a membrane‐bound carboxypeptidase that cleaves peptide hormones10.1016/S0021-9258(18)94167-0 ↗
88. Molecular cloning and sequencing of the cDNA for human membrane‐bound carboxypeptidase M: Comparison with carboxypeptidases A, B, H and N10.1016/S0021-9258(18)51610-0 ↗
89. 10.1074/jbc.270.26.1564410.1074/jbc.270.26.15644 ↗
90. 10.1111/j.1600-065X.1998.tb01576.x10.1111/j.1600-065X.1998.tb01576.x ↗
91. 10.1042/bj290015910.1042/bj2900159 ↗
92. 10.1083/jcb.136.2.43310.1083/jcb.136.2.433 ↗
93. 10.1074/jbc.274.24.1738410.1074/jbc.274.24.17384 ↗
94. 10.1074/jbc.C00021320010.1074/jbc.C000213200 ↗
95. 10.1152/ajpcell.1996.270.5.C131110.1152/ajpcell.1996.270.5.C1311 ↗
96. 10.1006/bbrc.1996.066010.1006/bbrc.1996.0660 ↗
97. 10.1006/bbrc.1996.083610.1006/bbrc.1996.0836 ↗
98. 10.1073/pnas.95.5.233710.1073/pnas.95.5.2337 ↗
99. 10.1074/jbc.273.19.1169510.1074/jbc.273.19.11695 ↗
100. ANP‐C‐receptor‐mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity